| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Clinical Operations
1 company
Kimberly Gentile is SVP, Clinical Operations at BHVN. Kimberly Gentile's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.6M at current prices.
Kimberly Gentile has 7 Form 4 filings on record from October 2022 to September 2026, all as SVP, Clinical Operations at Biohaven (BHVN), 2022–2026.
The 40 reported transactions were 16 other transactions, 14 option exercises, 7 option or other derivative awards and 3 tax withholdings.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria